SW:NYSESmurfit WestRock plc Analysis
Data as of 2026-05-28 - not real-time
$39.88
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Smurfit Westrock’s stock is trading below its short‑term moving averages, signaling a bearish technical backdrop, while the MACD shows a modest bullish crossover and the RSI hovers near the midpoint, indicating limited momentum. Fundamentally, the company carries a very high price‑to‑earnings multiple, a dividend payout that exceeds earnings by a wide margin, and a debt load that dwarfs its cash position, all of which point to an overvalued valuation profile. The recent capacity reductions and industry‑wide price hikes are intended to improve margins, and analysts have lifted price targets, suggesting upside potential if the operational turnaround materialises.
However, earnings missed expectations, volume is on a downtrend, and the dividend sustainability is questionable given the excessive payout ratio. Investors should weigh the short‑term price pressure against the medium‑term upside implied by higher pricing power and analyst targets, while remaining mindful of the high leverage and earnings volatility.
However, earnings missed expectations, volume is on a downtrend, and the dividend sustainability is questionable given the excessive payout ratio. Investors should weigh the short‑term price pressure against the medium‑term upside implied by higher pricing power and analyst targets, while remaining mindful of the high leverage and earnings volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Recent earnings miss and decreasing volume
- Price trading below key moving averages
- MACD showing only a modest bullish signal
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst price targets indicating significant upside
- Capacity cuts and price hikes improving margin outlook
- Forward earnings multiple moving into a more reasonable range
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Structural demand for packaging supporting a baseline growth story
- High leverage and low return metrics limiting upside
- Dividend policy that may force future cuts
Key Metrics & Analysis
Financial Health
Revenue Growth0.70%
Profit Margin1.22%
P/E Ratio55.4
ROE2.11%
ROA3.01%
Debt/Equity78.83
P/B Ratio1.1
Op. Cash Flow$3.4B
Free Cash Flow$1.4B
Technical Analysis
TrendBearish
RSI52.0
Support$35.53
Resistance$42.71
MA 20$39.22
MA 50$39.85
MA 200$41.19
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$9.24
Target Price$53.46
Upside/Downside34.06%
GradeOvervalued
TypeValue
Dividend Yield4.62%
Risk Assessment
Beta1.40
Volatility45.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.